How to Check Sudeep Pharma IPO Allotment Status on NSE, BSE, & MUFG Intime

The Sudeep Pharma IPO of ₹895 crore recently closed on November 25, 2025. Investors are now eager to find out if they have been allotted shares and understand what comes next. This blog explains how to check your IPO allotment status easily, and also provides brief but useful updates on the IPO’s subscription levels and its GMP, which indicates market expectations ahead of the public listing.

Important Dates

• Allotment Date: November 26, 2025
• Initiation of Refunds: November 27, 2025
• Credit of Shares to Demat: November 27, 2025
• Listing Date: November 28, 2025

How to Check the Allotment Status?

Here are three simple ways to check:

Option 1: On the NSE Website

• Visit the NSE IPO verification page at https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids
• Click on "Equity & SME IPO bid details"​
• Select "Sudeep Pharma" from the list​
• Enter your PAN or Application Number
• Click "Submit"​

Option 2: On the BSE India Website

• Go to the BSE allotment page at https://www.bseindia.com/investors/appli_check.aspx
• Under "Issue Type", select "Equity"
• From the "Issue Name" dropdown, choose "Sudeep Pharma"
• Enter either your PAN or Application Number​
• Click "Search" to view the status

Option 3: On MUFG Intime (registrar)

• Visit the official MUFG Intime IPO allotment page at https://in.mpms.mufg.com/Initial_Offer/public-issues.html
• From the dropdown menu, select "Sudeep Pharma"​
• Choose one of the following options:
  • PAN
  • Application Number (you got this when you applied)
  • DP/Client ID (your demat account number)​
• Click on "Submit"​

What Happens After Checking Allotment?

Once you know your allotment status:

• If Allotted: The shares will be credited to your demat account before the listing date (Nov 28, 2025). You can hold or sell the shares after they start trading, depending on your investment goal.
• If Not Allotted: The application money you paid will be refunded to your bank account within a few days after allotment. Make sure your bank details linked to your demat account are correct to avoid refund delays.
• Keep track of the listing price versus your IPO issue price so you can decide whether to sell or hold post-listing, based on your risk appetite.

For detailed information, visit Sudeep Pharma’s official IPO page at INDmoney.

IPO Subscription Details

• On Day 1, retail investors showed some interest (1.53 times), while qualified institutional buyers (QIB) were slow (only 0.09 times)
• Day 2 saw a big jump with retail at 5 times subscribed and non-institutional investors (NII) going up to 12 times
• By the final day, both retail and institutional subscriptions surged heavily, making the IPO 93.71 times subscribed overall, mostly driven by strong retail interest

GMP Update

This tells you the unofficial premium or listing gain expected before the shares start trading:

• On Nov 20, the GMP was ₹122, showing investors expected a 20.6% gain at listing
• It dropped a bit every day and stood at ₹86 on allotment day, meaning the expected gains softened but were still positive at about 14.5%

Disclaimer: GMP is an unofficial indicator and is subject to market volatility.

Final Word

Sudeep Pharma’s IPO has attracted strong interest, especially from retail investors, reflecting confidence in its niche specialty chemicals business. The allotment result will indicate how many investors actually get shares amid such heavy demand.

From a valuation standpoint, the IPO is priced on the higher side with a P/E ratio around 48 times FY25 profits, implying investors expect strong future growth, especially with the company’s focus on health ingredients materials.

Investors need to weigh the potential for medium-term growth against the risk of paying a premium. Checking your allotment status promptly and planning your holding or selling strategy post-listing will be key to making the most of this opportunity.

For more IPOs, check INDmoney’s IPO tracker here.

Disclaimer

Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. The securities are quoted as an example and not as a recommendation. This is nowhere to be considered as advice, recommendation, or solicitation of an offer to buy or sell or subscribe for securities. INDStocks SIP / Mini Save is a SIP feature that enables Customer(s) to save a fixed amount on a daily basis to invest in Indian stocks. INDstocks Private Limited (formerly known as INDmoney Private Limited) 616, Level 6, Suncity Success Tower, Sector 65, Gurugram, 122005, SEBI Stock Broking Registration No: INZ000305337, Trading and Clearing Member of NSE (90267, M70042) and BSE, BSE StarMF (6779), SEBI Depository Participant Reg. No. IN-DP-690-2022, Depository Participant ID: CDSL 12095500, Research Analyst Registration No. INH000018948 BSE RA Enlistment No. 6428. Refer to https://indstocks.com/pricing?type=indian-stocks; https://www.indstocks.com/page/indian-stocks-sip-terms-and-condition for further details.